Water Aerobics Session on Blood Pressure of Hypertensive Elderly.

NCT04545034 | Unknown DMC

• 1 other identifier: PPGMHR-001/20
• Study Type: interventional
• Target: 25
• Locations: 1 country
• Sites: 2

Brief Summary

This randomized controlled trial aimed to determine the subacute blood pressure effects of pharmacologically-treated elderly hypertensive patients after a single session of water aerobic exercise.

Conditions

Hypertension; Blood Pressure

Keywords

hypertension; water aerobic exercise; elderly; blood pressure

Outcome Measures

Primary Outcomes (1)

• Blood pressure after water aerobic exercise in elderly hipertensive

  Blood pressure was measured with the patient seated using an internationally validated semi-automatic BP monitor (Omron 705-CP, Matsusaka, Japan) following techniques adopted by The Seventh Report \[1\]. BP was measured before the session (Pre); immediately after (Min-0) and every 10 minutes until 60 minutes after the protocols had been performed (Min-10, Min-20, Min-30, Min-40, Min-50 and Min-60). The measurements were repeated at 2-minute intervals and the calculation of the mean of the two measurements.

  Baseline response to 10 days

Study Arms (2)

Water aerobic exercise protocol

EXPERIMENTAL

Walter aerobic exercise session would be used to treat blood pressure in elderly hypertensive people.

Other: water aerobic exercise

Control Group

NO INTERVENTION

No exercise intervention would be used.

Interventions

water aerobic exercise OTHER

The EP would be formed by continuous session of dynamic water aerobic exercise which consisted of a dynamic warm-up period (5 minutes), an active exercise period at the established intensity of HR (35 minutes), and a cooldown period (5 minutes) to total 45 minutes, with a intensity of 75%HR.

Water aerobic exercise protocol

Eligibility Criteria

• Age: 65 Years - 85 Years
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• age between 65 and 85 years;
• practice exercise (almost 3 days-week);
• use of anti-hypertensive drugs;
• systolic blood pressure (SBP) ≤160 mmHg and diastolic blood pressure (DBP) ≤100 mmHg documented by a physician

You may not qualify if:

• body mass index (BMI) \>35 kg/m2;
• decompensated diabetes mellitus and/or cardiac failure;
• active smoker;
• any febrile condition and/or infectious diseases;
• cardiovascular event in the 3 months preceding the study;
• hepatopathy;
• physical or mental limitations that prevent exercising.

Sponsors & Collaborators

• Centro Universitário de Anapolis: lead

Study Sites (2)

Centro Universitário de Anápolis - UniEVANGÉLICA

Anápolis, Goiás, 75083-515, Brazil

Location

Raphael Martins Da Cunha

Goiânia, Goiás, 74275-160, Brazil

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: This is a randomized crossover clinical trial carried out with 25 hypertensive women. The study procedures took place over three days with an interval of 48 hours, and included evaluation session, an experimental protocol (EP) and a control protocol (CP).

Study Record Dates

• First Submitted: August 25, 2020
• First Posted: September 10, 2020
• Study Start: April 1, 2020
• Primary Completion: July 30, 2020
• Study Completion: July 30, 2021
• Last Updated: September 10, 2020

Record last verified: 2020-09

Data Sharing

• IPD Sharing: Will not share

Locations

BR (2)